Melatonin is a feasible, safe and acceptable intervention in doctors and nurses working nightshifts: the MIDNIGHT trial

Bensita Mary Viju Jose Thottakam, Nigel R Webster, Lee Allen, Malachy O Columb, Helen F Galley* (Corresponding Author)

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

12 Citations (Scopus)
4 Downloads (Pure)

Abstract

Nightshift working is associated with sleep deprivation, fatigue and attention/concentration deficits which, in healthcare workers, may impact on patient safety. Clinical staff in the UK routinely work several 12h nightshifts in a row at about 1-3 month intervals. We investigated the feasibility and acceptability of a crossover trial of melatonin administration in clinical staff working nightshifts with an exploration of effects on sleep measures and attention/concentration tasks. This was a pilot, double-blinded, randomized, placebo-controlled crossover feasibility trial in doctors and nurses working 3 consecutive nightshifts at a tertiary referral hospital in the UK. Twenty five male and female subjects were randomized to receive either 6mg CircadinTM slow release melatonin or placebo before sleep after each consecutive nightshift, followed by a washout period, before crossing over to the other experimental arm. We used actigraphy for objective assessment of sleep parameters. The trial design was feasible and acceptable to participants with negligible side effects, but elevated melatonin levels were prolonged during the active arm (P=0.016). Double digit addition testing, a concentration/attention task, improved with melatonin treatment (P<0.0001). Lapses of vigilance or judgement whilst doctors or nurses are working nightshifts could impact on patient safety and melatonin may be a useful intervention. This study supports the conclusion that a larger definitive trial of this design is both feasible and safe.
Original languageEnglish
Article number872
Number of pages12
JournalFrontiers in psychiatry
Volume11
DOIs
Publication statusPublished - 27 Aug 2020

Bibliographical note

Funding:
The study was funded by the British Journal of Anaesthesia and the Royal College of Anaesthetists, funding partners of the National Institute of Academic Anaesthesia (grant number WKR0-2015-0027).
Acknowledgments:
We are extremely grateful to Flynn Pharma for the gift of Circadin and placebo tablets for this trial, to Gary Cameron for the assay of melatonin, and to Sally Galt for helping with recruitment. We also thank Drs Lorna Aucott and David McClernon of the medical statistics team for help with randomization. We acknowledge the members of the Trial Steering Group and the Data and Safety Monitoring Committee. Finally we thank all the doctors and nurses who took part in this trial.

Keywords

  • melatonin
  • randomized controlled trial
  • shift work
  • sleep
  • healthcare workers
  • PSYCHOMOTOR VIGILANCE
  • SLEEP
  • IMPACT
  • SHIFT WORK
  • PERFORMANCE
  • GENDER

Fingerprint

Dive into the research topics of 'Melatonin is a feasible, safe and acceptable intervention in doctors and nurses working nightshifts: the MIDNIGHT trial'. Together they form a unique fingerprint.

Cite this